SANTA CLARA, Calif., Dec. 14, 2022 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of ...

You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. DEAR DR. ROACH: Some months ago, my doctor used a QuantaFlo test to measure ...

The CMS advanced notice for Medicare advantage for the year 2024 removed the PAD HCC code QuantaFlo uses. This could negatively impact QuantaFlo's usage. Semler's stock crashed as a result. I'm not ...

Semler Scientific's primary product, QuantaFlo, is a fast and easy-to-use device for diagnosing peripheral arterial disease. Its stock has dropped nearly 50% in value, presenting a potential ...

Some months ago, my doctor used a QuantaFlo test to measure circulation in my legs. My result was low -- 0.69 versus the normal range of 0.9-1.40. I was not surprised, as poor circulation runs in the ...

Dear Dr. Roach: Some months ago, my doctor used a QuantaFlo test to measure circulation in my legs. My result was low — 0.69 versus the normal range of 0.9-1.40. I was not surprised, as poor ...

Semler's Q1 revenue and earnings fell well short of analysts' expectations. A new independent study, though, could boost future sales of the company's QuantaFlo test. Semler announced Q1 revenue of ...